Literature DB >> 3147460

Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats.

G G Nomikos1, C Spyraki.   

Abstract

The possibility that 5-HT2 receptors mediate the reinforcing properties of d-amphetamine, morphine and diazepam was investigated in rats, using ritanserin, a 5-HT2 antagonist, and the conditioned place preference paradigm. Ritanserin 1 or 2.5 mg/kg did not cause place conditioning. Place preference induced by 1.5 mg/kg d-amphetamine and 2 mg/kg morphine was inhibited and attenuated respectively by pretreatment with 2.5 mg/kg ritanserin. Diazepam- (1 mg/kg) induced place preference was completely blocked by both doses of ritanserin. Ritanserin pretreatment failed to influence amphetamine-induced hyperlocomotion, morphine-induced analgesia and diazepam-induced increased open arm exploration of rats on the elevated plus maze. These data are discussed in terms of (a) the possibility that serotoninergic mechanisms have a role in mediating reinforcement and (b) the relationship between appetitive properties and specific behavioral effects of psychostimulants, opiates and anxiolytics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147460     DOI: 10.1016/0091-3057(88)90110-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment.

Authors:  C Dugovic; T F Meert; D Ashton; G H Clincke
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.

Authors:  I Sora; F S Hall; A M Andrews; M Itokawa; X F Li; H B Wei; C Wichems; K P Lesch; D L Murphy; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists.

Authors:  T S Shippenberg; R Bals-Kubik; A Huber; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists.

Authors:  M Papp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Female Japanese quail with high levels of estradiol demonstrate cocaine-induced conditioned place preference.

Authors:  Karin E Gill; Anna R Reynolds; Mark A Prendergast; Chana K Akins
Journal:  Exp Clin Psychopharmacol       Date:  2016-03-10       Impact factor: 3.157

6.  Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration.

Authors:  J M Finlay; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?

Authors:  Joseph A Schroeder; Nicholas G Tolman; Faye F McKenna; Kelly L Watkins; Sara M Passeri; Alexander H Hsu; Brittany R Shinn; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

8.  Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.

Authors:  Eagle Y-K Huang; Te-Chen Liu; Pao-Luh Tao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

Review 9.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

10.  Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.

Authors:  Matthew F Lazenka; Bruce E Blough; S Stevens Negus
Journal:  J Sex Med       Date:  2016-01-28       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.